Suppr超能文献

囊性纤维化患儿和正常儿童在乙酰甲胆碱激发试验期间的喘息和气流阻塞。

Wheezing and airflow obstruction during methacholine challenge in children with cystic fibrosis and in normal children.

作者信息

Sanchez I, Powell R E, Pasterkamp H

机构信息

Department of Pediatrics, University of Manitoba, Winnipeg, Canada.

出版信息

Am Rev Respir Dis. 1993 Mar;147(3):705-9. doi: 10.1164/ajrccm/147.3.705.

Abstract

To study wheeze as an indicator of bronchial responses during standardized methacholine challenge (MCH), we used computerized analysis of respiratory sounds in children with cystic fibrosis (CF) and in healthy control subjects. We recorded tracheal and lung sounds from 10 young CF = yCF patients, mean age 5.7 yr (range 4 to 7 yr), 13 older CF = oCF, age 10.5 yr (8 to 18 yr), 7 young normal subjects = yNO, age 5.3 yr (4 to 7 yr), and 11 older normal subjects = oNO, age 11 yr (8 to 16 yr). Spirometry was obtained after each doubling concentration of methacholine until the concentration provoking a > or = 20% fall in FEV1 (PC20) or the end point (8 mg/ml) was reached. Sound and calibrated flow signals were recorded on tape and later analyzed by respirosonography. The concentration of methacholine associated with wheeze (PCw) was noted. Wheezing was quantified by its duration during inspiration (Tw/TI) and expiration (TW/TE). We found a positive response to MCH in 11 of 13 oCF (PC20 0.75 mg/ml, range 0.08 to 3.0) and in 3 of 11 oNO (PC20 4.2 mg/ml, range 2.5 to 6.5). Wheezing occurred in 6 oCF (PC20 < 8 mg/ml). In 7 yCF PC20 or PCW developed (1.51 mg/ml, range 0.125 to 4.0) versus 4 yNO (4.0 mg/ml, range 2.0 to 8.0). In 10 oCF subjects who performed MCH on three occasions within a 2-wk period, both positive and negative wheeze responses were reproducible. Patients who wheezed had a lower FRC compared with patients who did not (109 versus 147% of predicted, p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为研究在标准化乙酰甲胆碱激发试验(MCH)期间喘鸣作为支气管反应指标的情况,我们对囊性纤维化(CF)患儿和健康对照者的呼吸音进行了计算机分析。我们记录了10名年轻CF患儿(yCF)、平均年龄5.7岁(范围4至7岁)、13名年长CF患儿(oCF)、年龄10.5岁(8至18岁)、7名年轻正常受试者(yNO)、年龄5.3岁(4至7岁)以及11名年长正常受试者(oNO)、年龄11岁(8至16岁)的气管和肺部声音。每次乙酰甲胆碱浓度加倍后进行肺活量测定,直至达到引起第一秒用力呼气容积(FEV1)下降≥20%的浓度(PC20)或终点(8毫克/毫升)。声音和校准后的流量信号记录在磁带上,随后通过呼吸超声心动图进行分析。记录与喘鸣相关的乙酰甲乙酰甲胆碱浓度(PCw)。通过喘鸣在吸气(Tw/TI)和呼气(TW/TE)期间的持续时间对喘鸣进行量化。我们发现13名oCF中有11名对MCH有阳性反应(PC20为0.75毫克/毫升,范围0.08至3.0),11名oNO中有3名(PC20为4.2毫克/毫升,范围2.5至6.5)。6名oCF出现喘鸣(PC20<8毫克/毫升)。7名yCF出现PC20或PCW(1.51毫克/毫升,范围0.125至4.0),而4名yNO为(4.0毫克/毫升,范围2.0至8.0)。在10名在2周内进行三次MCH的oCF受试者中,阳性和阴性喘鸣反应均可重复。与未喘鸣的患者相比,喘鸣患者的功能残气量较低(分别为预测值的109%和147%,p<0.05)。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验